Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin

Kostantin Dobrenis, Ansamma Joseph, Mario C. Rattazzi

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Development of a strategy for efficient delivery of exogenous enzyme to neuronal lysosomes is essential to achieve enzyme replacement in neurodegenerative lysosomal storage diseases. We tested whether effective lysosomal targeting of the human enzyme β-N-acetylhexosaminidase A (Hex A; β-N-acetyl-D-hexosaminide N-acetylhexosaminohydrolase, EC 3.2.1.52) can be obtained by coupling it via disulfide linkage to the atoxic fragment C of tetanus toxin (TTC) that is bound avidly by neuronal membrane. TTC-Hex A conjugation resulted in neuronal surface binding and enhanced endocytosis of enzyme as observed in immunofluorescence studies with rat brain cultures. In immunoelectrophoretic quantitative uptake studies, rat neuronal cell cultures contained 16- and 40-fold greater amounts of enzyme after incubation with TTC-Hex A than with nonderivatized Hex A. In cerebral cortex cell cultures from a feline model of human GM2 gangliosidosis (Tay-Sachs and Sandhoff diseases), binding and uptake patterns of the enzymes were similar to those in the rat brain cell cultures. After exposure to extracellular concentrations of enzyme attainable in vivo, lysosomal storage of immunodetectable GM2 ganglioside was virtually eliminated in neurons exposed to TTC-Hex A, whereas a minimal effect was observed with Hex A. These findings demonstrate the usefulness of TTC adducts for effective neuronal lysosomal enzyme replacement.

Original languageEnglish (US)
Pages (from-to)2297-2301
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume89
Issue number6
StatePublished - 1992

Fingerprint

Hexosaminidase A
Enzymes
Cell Culture Techniques
GM2 Gangliosidosis
Sandhoff Disease
G(M2) Ganglioside
Tay-Sachs Disease
Lysosomal Storage Diseases
tetanus toxin fragment C
Felidae
Brain
Endocytosis
Lysosomes
Disulfides
Cerebral Cortex
Fluorescent Antibody Technique
Neurons
Membranes

Keywords

  • β-hexosaminidase
  • Brain cell culture
  • Endocytosis
  • GM2 ganglioside
  • Storage disease

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin. / Dobrenis, Kostantin; Joseph, Ansamma; Rattazzi, Mario C.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 89, No. 6, 1992, p. 2297-2301.

Research output: Contribution to journalArticle

@article{54f7d0bf77d441e9b1ad888dd18c286a,
title = "Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin",
abstract = "Development of a strategy for efficient delivery of exogenous enzyme to neuronal lysosomes is essential to achieve enzyme replacement in neurodegenerative lysosomal storage diseases. We tested whether effective lysosomal targeting of the human enzyme β-N-acetylhexosaminidase A (Hex A; β-N-acetyl-D-hexosaminide N-acetylhexosaminohydrolase, EC 3.2.1.52) can be obtained by coupling it via disulfide linkage to the atoxic fragment C of tetanus toxin (TTC) that is bound avidly by neuronal membrane. TTC-Hex A conjugation resulted in neuronal surface binding and enhanced endocytosis of enzyme as observed in immunofluorescence studies with rat brain cultures. In immunoelectrophoretic quantitative uptake studies, rat neuronal cell cultures contained 16- and 40-fold greater amounts of enzyme after incubation with TTC-Hex A than with nonderivatized Hex A. In cerebral cortex cell cultures from a feline model of human GM2 gangliosidosis (Tay-Sachs and Sandhoff diseases), binding and uptake patterns of the enzymes were similar to those in the rat brain cell cultures. After exposure to extracellular concentrations of enzyme attainable in vivo, lysosomal storage of immunodetectable GM2 ganglioside was virtually eliminated in neurons exposed to TTC-Hex A, whereas a minimal effect was observed with Hex A. These findings demonstrate the usefulness of TTC adducts for effective neuronal lysosomal enzyme replacement.",
keywords = "β-hexosaminidase, Brain cell culture, Endocytosis, GM2 ganglioside, Storage disease",
author = "Kostantin Dobrenis and Ansamma Joseph and Rattazzi, {Mario C.}",
year = "1992",
language = "English (US)",
volume = "89",
pages = "2297--2301",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "6",

}

TY - JOUR

T1 - Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin

AU - Dobrenis, Kostantin

AU - Joseph, Ansamma

AU - Rattazzi, Mario C.

PY - 1992

Y1 - 1992

N2 - Development of a strategy for efficient delivery of exogenous enzyme to neuronal lysosomes is essential to achieve enzyme replacement in neurodegenerative lysosomal storage diseases. We tested whether effective lysosomal targeting of the human enzyme β-N-acetylhexosaminidase A (Hex A; β-N-acetyl-D-hexosaminide N-acetylhexosaminohydrolase, EC 3.2.1.52) can be obtained by coupling it via disulfide linkage to the atoxic fragment C of tetanus toxin (TTC) that is bound avidly by neuronal membrane. TTC-Hex A conjugation resulted in neuronal surface binding and enhanced endocytosis of enzyme as observed in immunofluorescence studies with rat brain cultures. In immunoelectrophoretic quantitative uptake studies, rat neuronal cell cultures contained 16- and 40-fold greater amounts of enzyme after incubation with TTC-Hex A than with nonderivatized Hex A. In cerebral cortex cell cultures from a feline model of human GM2 gangliosidosis (Tay-Sachs and Sandhoff diseases), binding and uptake patterns of the enzymes were similar to those in the rat brain cell cultures. After exposure to extracellular concentrations of enzyme attainable in vivo, lysosomal storage of immunodetectable GM2 ganglioside was virtually eliminated in neurons exposed to TTC-Hex A, whereas a minimal effect was observed with Hex A. These findings demonstrate the usefulness of TTC adducts for effective neuronal lysosomal enzyme replacement.

AB - Development of a strategy for efficient delivery of exogenous enzyme to neuronal lysosomes is essential to achieve enzyme replacement in neurodegenerative lysosomal storage diseases. We tested whether effective lysosomal targeting of the human enzyme β-N-acetylhexosaminidase A (Hex A; β-N-acetyl-D-hexosaminide N-acetylhexosaminohydrolase, EC 3.2.1.52) can be obtained by coupling it via disulfide linkage to the atoxic fragment C of tetanus toxin (TTC) that is bound avidly by neuronal membrane. TTC-Hex A conjugation resulted in neuronal surface binding and enhanced endocytosis of enzyme as observed in immunofluorescence studies with rat brain cultures. In immunoelectrophoretic quantitative uptake studies, rat neuronal cell cultures contained 16- and 40-fold greater amounts of enzyme after incubation with TTC-Hex A than with nonderivatized Hex A. In cerebral cortex cell cultures from a feline model of human GM2 gangliosidosis (Tay-Sachs and Sandhoff diseases), binding and uptake patterns of the enzymes were similar to those in the rat brain cell cultures. After exposure to extracellular concentrations of enzyme attainable in vivo, lysosomal storage of immunodetectable GM2 ganglioside was virtually eliminated in neurons exposed to TTC-Hex A, whereas a minimal effect was observed with Hex A. These findings demonstrate the usefulness of TTC adducts for effective neuronal lysosomal enzyme replacement.

KW - β-hexosaminidase

KW - Brain cell culture

KW - Endocytosis

KW - GM2 ganglioside

KW - Storage disease

UR - http://www.scopus.com/inward/record.url?scp=0026510667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026510667&partnerID=8YFLogxK

M3 - Article

C2 - 1532255

AN - SCOPUS:0026510667

VL - 89

SP - 2297

EP - 2301

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 6

ER -